Masanao Kurata

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Goro Honda · 14 shared papers, 2013–2019 · strength 0.73
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper [Neoadjuvant Chemotherapy Using S-1 for Pancreatic Cancer - Mid-Term Results]. PMID 27760934↗
2. Sohei Satoi · 12 shared papers, 2015–2019 · strength 0.64
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
3. Michiaki Unno · 12 shared papers, 2015–2019 · strength 0.64
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
4. Fuyuhiko Motoi · 12 shared papers, 2015–2019 · strength 0.64
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
5. Yoshiaki Murakami · 11 shared papers, 2015–2019 · strength 0.58
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
6. Masayuki Sho · 11 shared papers, 2015–2019 · strength 0.58
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
7. Hiroki Yamaue · 11 shared papers, 2015–2019 · strength 0.58
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
8. Kenichiro Uemura · 11 shared papers, 2015–2019 · strength 0.58
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
9. Ippei Matsumoto · 11 shared papers, 2015–2019 · strength 0.58
   • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
   • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
   • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
10. Hiroaki Yanagimoto · 10 shared papers, 2015–2019 · strength 0.55
    • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
    • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
    • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
11. Takumi Fukumoto · 10 shared papers, 2015–2019 · strength 0.51
    • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
    • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
    • Paper Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Panc… DOI 10.1007/s00268-017-4077-5↗
12. Manabu Kawai · 8 shared papers, 2015–2018 · strength 0.38
    • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
    • Paper Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Panc… DOI 10.1007/s00268-017-4077-5↗
    • Paper Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observatio… DOI 10.1016/j.surg.2016.02.032↗
13. Terumi Kamisawa · 4 shared papers, 2011–2026 · strength 0.35
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
    • Paper A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic… PMID 26902051↗
    • Paper Pancreatic cancer as the fourth cancer in a patient with Peutz-Jeghers syndrome and a history of familial pancreatic ca… DOI 10.1097/mpa.0b013e3181ea6147↗
14. Masamichi Mizuma · 5 shared papers, 2015–2019 · strength 0.30
    • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
    • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
    • Paper Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma … DOI 10.1097/sla.0000000000001705↗
15. Kazuro Chiba · 2 shared papers, 2013–2026 · strength 0.27
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
    • Paper Pancreatic cancer causing acute pancreatitis: a comparative study with cancer patients without pancreatitis and pancrea… DOI 10.1007/s00534-013-0598-y↗
16. Ken‐ichi Okada · 4 shared papers, 2016–2019 · strength 0.27
    • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
    • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
    • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
17. Minako Nagai · 5 shared papers, 2015–2019 · strength 0.26
    • Paper Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with… DOI 10.1186/s12885-019-5460-4↗
    • Paper Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Panc… DOI 10.1007/s00268-017-4077-5↗
    • Paper Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. DOI 10.1002/jhbp.320↗
18. Jun Nakahodo · 1 shared paper, 2026 · strength 0.24
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
19. Ryogo Minami · 1 shared paper, 2026 · strength 0.24
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
20. Masakazu Toi · 1 shared paper, 2026 · strength 0.24
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
21. Masataka Kikuyama · 1 shared paper, 2026 · strength 0.24
    • Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
22. Takahiro Akahori · 5 shared papers, 2015–2018 · strength 0.23
    • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
    • Paper Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. DOI 10.1002/jhbp.320↗
    • Paper Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matche… DOI 10.1097/mpa.0000000000000579↗
23. Shoichi Kinoshita · 4 shared papers, 2015–2019 · strength 0.21
    • Paper Sustained Elevation of Postoperative Serum Level of Carbohydrate Antigen 19-9 is High-Risk Stigmata for Primary Hepatic… DOI 10.1007/s00268-018-4814-4↗
    • Paper Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. DOI 10.1002/jhbp.320↗
    • Paper Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matche… DOI 10.1097/mpa.0000000000000579↗
24. Tomohisa Yamamoto · 4 shared papers, 2015–2018 · strength 0.20
    • Paper Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic duc… DOI 10.1016/j.pan.2017.11.005↗
    • Paper Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma … DOI 10.1097/sla.0000000000001705↗
    • Paper Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matche… DOI 10.1097/mpa.0000000000000579↗
25. Yoshiyuki Nakajima · 4 shared papers, 2015–2016 · strength 0.17
    • Paper Grade B pancreatic fistulas do not affect survival after pancreatectomy for pancreatic cancer: A multicenter observatio… DOI 10.1016/j.surg.2016.02.032↗
    • Paper Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. DOI 10.1002/jhbp.320↗
    • Paper Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patient… DOI 10.1007/s00535-014-1005-4↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.